Healthcare returned -3.2% in June, extending its year-to-date outperformance versus global equities to 10.2%. In June, central banks were in the limelight as hopes that inflation had peaked were again crushed. The FED then proceeded with its largest rate hike since 1994 – hinting of another hefty 75 bp increase in July. Ditto for the ECB, which confirmed a 25 bp hike for July. And even the Swiss National Bank surprised markets with its first hike (50 bp) in 15 years. These central bank actions and ongoing worries of a FED-induced soft landing caused global equities to drop 8.7% in June.
Detecting cancer early on can make such a big difference. The good news is that cancer screening will get much easier in the future.
February was a month of twists and turns for the healthcare industry! From the ebb and flow of macro dynamics to the ups and downs of the Q4 reporting season, healthcare stocks experienced a flurry of activity. Meanwhile, the Medtech, Pharma, and Providers space saw a surge of M&A activity. More in this month’s commentary.
Did you know that every 34 seconds a person dies in the United States from cardiovascular disease? It’s the leading cause not only in the US, but also globally.